Priority Date: 24.08.07 (EP 20070016637)

Mutant double cyclized receptor peptides inhibiting beta 1-adrenoceptor antibodies

  • Application ID: EP12178671
  • Status: NO OPPOSITION FILED WITHIN TIMELIMIT

Attorney

Employment test 51 - 200 employees
Company dna vossius and partner
operating since 1961
Headquarter in Munich and 3 offices
active in Legal Services and IP-related Communication Service

Specialization

This EP application has the IPC combination A61, C07, and G01. We found, that TransMIT GmbH, Kailuweit & Uhlemann, dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB, Avidity IP Ltd, Mewburn Ellis LLP and 55 others are specialized in this combination either. For a similar patent, they might be a good choice.

Timeline

  • 24.08.2007 - Priority Date (EP 20070016637)
  • 20.02.2013 - Publication A2 (EP2559698)
  • 06.03.2013 - Publication A3 (EP2559698)
  • 12.11.2014 - Publication B1 (EP2559698)